Plasmid DNA Manufacturing Technology - Co-Developed By Boehringer Ingelheim Austria With BIA Separations
10/19/2005 5:13:05 PM
VIENNA, Austria & LJUBLJANA, Slovenia--(BUSINESS WIRE)--March 22, 2005--Boehringer Ingelheim Austria GmbH, Vienna, and BIA Separations d.o.o., Ljubljana, are pleased to announce a technological innovation in the field of plasmid DNA (pDNA) manufacture.
To meet the growing need for pharmaceutical grade pDNA, Boehringer Ingelheim Austria has developed a high cell density fermentation technology achieving titers up to 1 g pDNA per Liter, and has specifically designed equipment for the automated and gentle lysis of the biomass. A key and novel element of the production process is the use of CIM Convection Interaction Media(R) short monolithic columns for the purification of pDNA. The fast separation speed, outstanding capacity, and excellent separation power of CIM(R) columns, developed by BIA Separations, allows a 15-fold increase in productivity compared to traditional supports. "Our customers clearly benefit from this new development as the process is free of antibiotics, animal-derived raw materials, enzymes and organic solvents and employs the powerful CIM(R) separation technology" says Dr. Kurt Konopitzky, Head of the Division Biopharmaceuticals/Operations at Boehringer Ingelheim Austria.